pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT05634720: Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Sponsor: Duke University. Phase: PHASE4. Conditions: Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05571982: Comparison of the Efficacy of Tidal Volume Breathing and Vital Capacity Breathing During High-flow Nasal Oxygen

Sponsor: Yonsei University. Phase: NA. Conditions: Adult Patients 20 Years of Age or Older Who Are Planning to Undergo Surgery Under General Anesthesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06384924: Raman Spectroscopy and Skin Cancer

Sponsor: Tiezhi Zhang. Phase: . Conditions: Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07622459: Circadian Feeding and Reciprocal Scent Intervention in NICU

Sponsor: Inonu University. Phase: NA. Conditions: Prematurity, Mechanical Ventilation

full page →ctgov ↗
›COMPLETEDphase readoutNCT03325959: Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Hyperbaric Oxygen

full page →ctgov ↗
›RECRUITINGphase readoutNCT07469059: Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy

Sponsor: University of Erlangen-Nürnberg Medical School. Phase: . Conditions: Nephritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06587880: The Effect of Different Types of Mouthwash on Extraction Sockets' Healing

Sponsor: University of Jordan. Phase: PHASE4. Conditions: Extraction Socket Healing, Quality of Life, Postoperative Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT03869996: Total Knee Arthroplasty: Fast Track Protocol is the Future?

Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: Osteoarthritis, Knee, Arthropathy of Knee

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07604727: AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

Sponsor: University Medical Center Groningen. Phase: NA. Conditions: Atrial Fibrillation (AF), Heart Failure, Cardiac Pacing

full page →ctgov ↗
›COMPLETEDphase readoutNCT04716127: A Proximity-incentive Strategy for Cervical Cancer Screening

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Cervical Cancer, Uterine Cervical Disease, Human Papilloma Virus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05508061: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Sponsor: Inreda Diabetic B.V.. Phase: NA. Conditions: Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT02629042: Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis

Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: Pulpitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07624786: Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care

Sponsor: Erasmus Medical Center. Phase: . Conditions: Mechanical Ventilation, Patient-Ventilator Asynchrony

full page →ctgov ↗
›RECRUITINGphase readoutNCT06679270: Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Familial Partial Lipodystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07214870: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Fatty Liver Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07560969: Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans

Sponsor: University of Missouri, Kansas City. Phase: NA. Conditions: Diabetes, Physical Activity, Food Security, Nutrition Security

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07270783: Healthy Volunteer Study

Sponsor: InventisBio Co., Ltd. Phase: PHASE1. Conditions: Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06456983: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

Sponsor: Central Institute of Mental Health, Mannheim. Phase: NA. Conditions: Schizophrenia, Treatment Resistant Schizophrenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04602741: Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia, Schizo Affective Disorder, Psychotic Disorders

full page →ctgov ↗
›SUSPENDEDphase readoutNCT03588754: Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

Sponsor: Yale University. Phase: PHASE2. Conditions: Alcohol Drinking

full page →ctgov ↗
›RECRUITINGphase readoutNCT06144554: Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

Sponsor: Insulet Corporation. Phase: . Conditions: Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT01581554: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05012254: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Sponsor: Fundación GECP. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07064005: Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Sponsor: Pravat Mandal. Phase: PHASE1. Conditions: Parkinsons Disease (PD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07538505: Testing a Diabetes Care Program in Rural and Low-Income Clinics

Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT00340405: Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lung Cancer

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05924594: Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

Sponsor: Cingulate Therapeutics. Phase: PHASE3. Conditions: ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06253494: Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Endometrial Cancer, Cancer of Endometrium, Carcinoma of Endometrium, Endometrial Carcinoma

full page →ctgov ↗
›TERMINATEDphase readoutNCT05736666: Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Knee Osteoarthritis, Arthroplasty Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT05168566: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Sponsor: Teligene US. Phase: PHASE2. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07239466: A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Sponsor: Tao Zhang. Phase: PHASE2. Conditions: Rectal Cancer, Radiotherapy, Immunotherapy, Chemotherapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07529366: Pharmacist-Led Continuous Glucose Monitoring for Prediabetes

Sponsor: University of South Florida. Phase: . Conditions: Prediabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07409766: A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Advanced Malignant Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07355322: Comparison of a 3-step Bonding System (Transbond™ XT) and a 2-step System (GC Ortho Connect™) on Demineralization Around Maxillary Orthodontic Brackets

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Tooth Demineralization, White Spot Lesion, Demineralization, Orthodontic Appliance Complication, Dental Braces Complication

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06260722: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07343622: Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA

Sponsor: Zunyi Medical College. Phase: NA. Conditions: Total Colonic Aganglionosis, Hirschsprung Disease, Duhamel, Soave

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07446751: Long-term Outcomes of SMILE PRO for High Astigmatism

Sponsor: Hanoi Medical University. Phase: NA. Conditions: High Astigmatism

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05972551: Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta

full page →ctgov ↗
›COMPLETEDphase readoutNCT03726151: Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Human Papillomavirus Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07523451: COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT

Sponsor: Alexandria University. Phase: NA. Conditions: TMJ Disc Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05587751: Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

Sponsor: Mayo Clinic. Phase: NA. Conditions: Hormonal Gender-Affirming Therapy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07531251: Clinical Trial in Patients With Barth Syndrome- 4TAZPower

Sponsor: Stealth BioTherapeutics Inc.. Phase: PHASE4. Conditions: Barth Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT04410796: Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Metastatic Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06874296: Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Liver Transplantation, Liver Diseases, Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03743662: Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Glioblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05183646: A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Sponsor: Dimerix Bioscience Pty Ltd. Phase: PHASE3. Conditions: FSGS

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07357688: The Effect of Acupuncture Therapy on Cognitive Function in Post-COVID-19 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Sponsor: Xi Wu. Phase: NA. Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07326488: A Study of MHB009C in Patients With Advanced Solid Tumors

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd. Phase: PHASE1. Conditions: Advanced Malignant Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT03115203: Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Facial Paralysis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05436327: Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer, Aging, Communication

full page →ctgov ↗
← prev
page 61 of 104
next →